CVS releases 2016 formulary

Pharmacy benefit manager CVS Health Corp. (NYSE:CVS) released its 2016 formulary, which includes a list of 119 excluded drugs.

Multiple sclerosis (MS) drugs Plegridy peginterferon beta-1a from Biogen Inc. (NASDAQ:BIIB) and Extavia interferon beta-1b from Novartis AG (NYSE:NVS; SIX:NOVN) were moved to the excluded list; they are on the 2015 formulary. Biogen's Avonex interferon beta-1a was also excluded. ...